SLU-PP-332 Chemistry: ERR Agonist Standard
A bench-level reference sheet on SLU-PP-332, the non-peptide synthetic estrogen-related receptor agonist, covering how its small-molecule structure is built, characterized, and handled as a research reference standard.
Structure and Identity
SLU-PP-332 is a non-peptide synthetic small molecule rather than a chain of amino acid residues. Its structure is a defined organic scaffold, the kind of compact, drug-like architecture that reads on paper as a single small-molecule structure rather than a sequence. Because it is not a peptide, none of the residue-by-residue language used for the peptides in the catalog applies to it, and there is no sequence to enumerate or terminus to describe.
That distinction is the most practical fact to read off SLU-PP-332 first. As a small molecule it is handled, dissolved, and characterized using small-molecule conventions rather than peptide ones, so expectations for solubility, ionization, and storage follow from its organic structure. For research chemists who normally work with the peptide entries in the mitochondrial and metabolic overviews, SLU-PP-332 is the entry that behaves like an organic compound on the bench from the outset.
The ERR Agonist Family
SLU-PP-332 sits within the estrogen-related receptor agonist class. The estrogen-related receptors, ERRalpha, ERRbeta, and ERRgamma, are a family of orphan nuclear receptors associated with mitochondrial and metabolic gene programs, and SLU-PP-332 is studied as a small-molecule agonist that engages that receptor family. What unites this class is the shared receptor target rather than a shared chemical backbone, so its members are grouped by what they bind rather than by structural family.
Within the catalog SLU-PP-332 is placed with the mitochondrial-focused compounds, the set of standards studied for their connection to cellular energy pathways. It is useful to read it alongside the NAD+ overview and other mitochondrial entries, since each reaches that broad theme from a different chemical direction, which makes SLU-PP-332 a helpful contrast point when surveying how distinct scaffolds touch the same area of research.
Why a Synthetic Small-Molecule Route
Because SLU-PP-332 is not a peptide, it is not assembled by solid-phase peptide synthesis. It is produced by a synthetic small-molecule route, a multi-step organic synthesis that constructs its organic scaffold, installs the substituent groups, and resolves the relevant chemistry through conventional reaction and purification steps. The output is a defined organic compound isolated as a solid, not a chain built residue by residue on resin.
For the bench, the consequences of that route are worth anticipating. A small-molecule synthesis is governed by reaction yield, by control of byproducts and regiochemistry, and by final purification rather than by coupling efficiency along a growing chain. The resulting material tends to be more chemically uniform than a long peptide, which is one reason SLU-PP-332 is straightforward to verify against a defined target structure once the route is complete.
Characterization
Identity and purity for SLU-PP-332 are established with the same two complementary tools used across the reference catalog. Reversed-phase HPLC reports the purity figure, the percentage of the total peak area attributable to the target compound, and it separates the main product from closely related synthetic impurities and degradation species. Mass spectrometry confirms identity by matching the measured mass to the expected mass for the defined structure.
Reading these together matters. An HPLC purity number describes how much of the sample is the intended compound relative to other UV-absorbing species, while the mass result confirms that the main peak is in fact the right molecule rather than an isobaric impurity. Both pieces of information describe the chemistry of the structure, and documentation describing how identity and purity are confirmed is available on request for those who want the method detail.
Stability and Storage
As a dry solid, SLU-PP-332 is comparatively stable when kept cool, dry, and out of light. Long-term storage of the dry material is typically at refrigerated or freezer temperatures, with the container protected from moisture so the solid does not pick up water on opening. Allowing a sealed container to reach room temperature before it is opened helps avoid condensation on cold contents, the same general precaution that applies across the catalog.
Once in solution, the working preparation is less forgiving. Compounds in solution are subject to hydrolysis, oxidation, and adsorption to surfaces, so reconstituted material is generally held cold and used within a short window, with freeze-thaw cycles minimized. These are general handling principles for a research reference standard rather than claims about any one preparation, and the documentation for a given standard should be the reference of record for its own conditions.
What SLU-PP-332 Is Studied For (Chemistry Only)
In a research-chemistry context, SLU-PP-332 is of interest because it is a defined non-peptide tool compound for work on the estrogen-related receptor family. It lets chemists study how a small-molecule scaffold engages an orphan nuclear receptor target, and it serves as a stable, well characterized reference point when validating synthesis and analytical methods on related compounds. As a small molecule it is also a useful contrast to the peptide entries in the mitochondrial group.
That framing is deliberately limited to the bench. This material is a reference standard for laboratory research only, and nothing here describes or implies any human or veterinary use or outcome. The value of SLU-PP-332 to a research chemist is as a chemistry subject, a defined small-molecule structure whose behavior under synthesis, analysis, and storage is well understood and worth knowing in detail.
This overview is provided for laboratory and research use only. It is educational chemistry reference material and is not for human or veterinary consumption. Buyers are responsible for compliance with all applicable laws and regulations.
SLU-PP-332 chemistry, in brief
Is SLU-PP-332 a peptide?
No. SLU-PP-332 is a non-peptide small molecule. It is a synthetic estrogen-related receptor (ERR) agonist built on a defined organic scaffold rather than a chain of amino acid residues, so its chemistry is described as a small-molecule structure rather than a sequence.
What does SLU-PP-332 target?
SLU-PP-332 is studied as an agonist of the estrogen-related receptors (ERRalpha, ERRbeta and ERRgamma), a family of orphan nuclear receptors tied to mitochondrial and metabolic gene programs. In a chemistry context it is treated as a small-molecule tool compound for that receptor family, not a peptide.
How is SLU-PP-332 synthesized?
SLU-PP-332 is made by a synthetic small-molecule route, a multi-step organic synthesis that assembles its organic scaffold and substituent groups, rather than by solid-phase peptide synthesis. The final compound is isolated and handled as a defined small-molecule solid.
How should SLU-PP-332 reference material be stored?
As a dry solid, SLU-PP-332 is generally kept cool, dry, and out of light, with the container protected from moisture. Material in solution is less stable and is typically held cold and used within a short window. These are general handling principles for a research reference standard, for laboratory use only.